Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Madrid
Clinical trial register · Spain

Clinical Trials in Madrid, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca183 Janssen Research & Development, LLC109 Merck Sharp & Dohme LLC106 Novartis Pharmaceuticals100 Hoffmann-La Roche92
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Madrid

3046 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
SCAD : a Registry of Spontaneous Coronary Artery Dissection
NCT06601270Spontaneous Coronary Artery Dissection
European Society of Cardiology
Observational
1,500
Madrid
2021-01-30
Active, closed
Forma Therapeutics, Inc.
Phase 3
450
A Coruña, Badalona, Barakaldo, Barcelona, Madrid, Seville
2021-01-29
Active, closed
AstraZeneca
Phase 3
1,371
Barcelona, Jaén, Lleida, Madrid, Málaga, Pamplona, Santander, Seville
2021-01-28
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT04657068Advanced Cancer, Metastatic Cancer, Ovarian Cancer, Primary Peritoneal Cancer
DrugsIrinotecan·Gemcitabine
Artios Pharma Ltd
Phase 1/2
542
Elche, Sabadell, Santander, Barcelona, Lleida, Madrid, Pozuelo de Alarcón, El Palmar
2021-01-27
Recruiting
BioInvent International AB
Phase 1/2
250
Barcelona, Madrid
2021-01-25
Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
NCT04031677Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
250
Barcelona, Madrid
2021-01-20
Recruiting
Hospital Universitari de Bellvitge
Not applicable
100
Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid
2021-01-20
Active, closed
Hoffmann-La Roche
Phase 2
920
Esplugues de Llobregas, Barcelona, Madrid, Valencia
2021-01-18
Recruiting
Pfizer
Phase 3
2,100
Santander, Barcelona, Madrid, Seville, Valladolid
2021-01-15
Active, closed
Toralf Reimer, MD PhD
Not applicable
350
Madrid
2021-01-13
Active, closed
Genmab
Phase 3
483
Badalona, Barcelona, Cadiz, Cáceres, Córdoba, Lleida, Madrid, Salamanca
2021-01-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Girona, Madrid, Barcelona, Córdoba
2021-01-10
Active, closed
Goat Infant Formula Feeding and Eczema (the GIraFFE Study)
NCT04599946Dermatitis, Atopic, Eczema, Infantile, Infant Development, Child Development
Dairy Goat Co-operative (N.Z.) Limited
Not applicable
2,132
Almería, Granada, Madrid, Reus, Tarragona, Valencia, Zaragoza
2021-01-08
Active, closed
BioNTech SE
Phase 2/3
358
Barcelona, Girona, Jaén, Madrid, Majadahonda, Málaga, Palma de Mallorca, Valencia
2021-01-07
Recruiting
Peri-Implant and Peri-Prosthetic Fractures: Epidemiology, Morbidity, Mortality, Treatment and Outcome Analysis
NCT04663893Periprosthetic Fracture of the Upper or Lower Limb, Peri-implant Fracture of the Upper or Lower Limb, Periprosthetic Fractures, Peri-implant Fracture
Hospital Clínico Universitario de Valladolid
Observational
2,500
Barcelona, Gijón, Madrid, Valladolid
2021-01-01
Recruiting
Effect of Fetal Aortic Valvuloplasty on Outcomes
NCT05386173Congenital Heart Disease, Aortic Valve Stenosis, Fetal Cardiac Disorder, Hypoplastic Left Heart Syndrome
Queen Silvia Children's Hospital, Gothenburg, Sweden
Observational
200
Madrid
2021-01-01
Active, closed
A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations
NCT04639219Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
DrugTrastuzumab deruxtecan
AstraZeneca
Phase 2
102
Barcelona, Madrid, Pamplona, Seville
2020-12-30
Active, closed
Replimune, Inc.
Phase 1
123
Barcelona, Madrid, Valencia
2020-12-29
Active, closed
AstraZeneca
Phase 1/2
245
Barcelona, L'Hospitalet de Llobregat, Madrid, Seville
2020-12-28
Active, closed
Pullback Pressure Gradient (PPG) Global Registry
NCT04789317Chronic Coronary Insufficiency, Non ST Elevation Myocardial Infarction
VZW Cardiovascular Research Center Aalst
Observational
982
Madrid
2020-12-23
Recruiting
Spanish Registry of Digestive Tumours RETUD
NCT06711211Digestive Cancers, Bile Duct Cancer, Hepatocellular Cancer (HCC), Colorectal Cancer (CRC)
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Observational
20,000
Madrid
2020-12-23
Recruiting
Secukinumab Open Label Roll-over Extension Protocol
NCT04638647Autoimmunity, Inflammation
DrugSecukinumab
Novartis Pharmaceuticals
Phase 4
1,000
Santiago Compostela, Málaga, L'Hospitalet de Llobregat, Bilbao, Santander, Vigo, A Coruña, Madrid
2020-12-22
Active, closed
Daiichi Sankyo
Phase 3
605
Barcelona, Madrid, Málaga, Ourense, Seville, Valencia, Zaragoza
2020-12-21
Active, closed
Pfizer
Phase 3
841
Santiago de Compostela, Elche, L'Hospitalet de Llobregat, Barcelona, Madrid, Seville, Valencia, Zaragoza
2020-12-21
Active, closed
Regeneron Pharmaceuticals
Phase 1/2
548
Sant Cugat del Vallès, Pozuelo de Alarcón, Barcelona, Madrid, Valencia
2020-12-21
Active, closed
Verastem, Inc.
Phase 2
225
Barcelona, Córdoba, Madrid, Valencia
2020-12-21
Active, closed
Janssen Research & Development, LLC
Phase 2
220
A Coruña, Badalona, Barcelona, Cadiz, Granada, Jerez de la Frontera, Madrid, Málaga
2020-12-18
Active, closed
Novartis Pharmaceuticals
Phase 2
17
Madrid
2020-12-18
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
182
Barcelona, Madrid
2020-12-18
Active, closed
Neurocrine Biosciences
Phase 3
182
Madrid, Seville
2020-12-16
Active, closed
AstraZeneca
Phase 3
358
Barcelona, Madrid, Majadahonda, Málaga
2020-12-16
Active, closed
Janssen Research & Development, LLC
Phase 1/2
228
Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Salamanca, Santander
2020-12-15
Recruiting
FS222 First in Human Study in Patients With Advanced Malignancies
NCT04740424Advanced Cancer, Metastatic Cancer
invoX Pharma Limited
Phase 1
260
Pamplona, Barcelona, Las Palmas de Gran Canaria, Madrid, Majadahonda, Seville, Valencia
2020-12-14
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
DrugsAtrasentan·Zigakibart
Novartis Pharmaceuticals
Phase 3
404
Barcelona, Madrid, Sagunto, Seville, Valencia
2020-12-11
Active, closed
CatalYm GmbH
Phase 1/2
199
Barcelona, Madrid, Pamplona
2020-12-09
Active, closed
GlaxoSmithKline
Phase 2/3
758
A Coruña, Badalona, Barcelona, Burgos, Córdoba, Las Palmas de Gran Canar, Madrid, Málaga
2020-12-08
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
612
Santiago de Compostela, Girona, Madrid
2020-12-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
L'Hospitalet de Llobregat, Oviedo, Barcelona, Madrid, Málaga, Seville
2020-12-08
Active, closed
Janssen Research & Development, LLC
Phase 3
518
A Coruña, Badalona, Barcelona, Granada, Jerez de la Frontera, Madrid, Sabadell, Santander
2020-12-07
Active, closed
MeiraGTx Ocular UK Ltd
Phase 3
97
Madrid
2020-12-04
Active, closed
Amgen
Phase 3
135
Barcelona, Madrid, Valencia
2020-12-04
Recruiting
International Validation of Two Non-motor Scales in PD (NFS and SPARK)
NCT04366804Parkinson's Disease, Non-motor Symptoms
Insel Gruppe AG, University Hospital Bern
Observational
300
Burgos, Madrid
2020-12-03
Active, closed
Hoffmann-La Roche
Phase 3
769
Pozuelo de Alarcón, Barcelona, Madrid, Murcia
2020-12-03
Active, closed
University Hospital, Basel, Switzerland
Not applicable
64,374
Barcelona, Madrid, Valencia
2020-12-01
Active, closed
PARADIGM: Amplatzer Valvular Plug for PVL Closure
NCT04489823Paravalvular Aortic Regurgitation
Abbott Medical Devices
Not applicable
200
Madrid, Salamanca
2020-12-01
Active, closed
José Carlos Marín Gabriel
Not applicable
236
Madrid
2020-12-01
Active, closed
Instituto de Investigación Hospital Universitario La Paz
Phase 1/2
18
Santiago de Compostela, Oviedo, Barcelona, Madrid, Málaga, Murcia, Seville, Valencia
2020-11-30
Active, closed
XVIVO Perfusion
Not applicable
230
Madrid
2020-11-25
Active, closed
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Treatment-naïve High Risk Chronic Lymphocytic Leukemia
DrugsEpcoritamab·Pirtobrutinib·Lenalidomide·Venetoclax
Genmab
Phase 1/2
194
Barcelona, Coaña, Madrid, Seville, Valencia
2020-11-25
Recruiting
Alnylam Pharmaceuticals
Observational
1,500
Barcelona, Madrid, Palma
2020-11-23
Active, closed
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
NCT04603001Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasms (MPNs)
DrugsLY3410738·Azacitidine·Venetoclax
Eli Lilly and Company
Phase 1
260
Barcelona, Madrid, Valencia
2020-11-19
Active, closed
FS120 Phase 1/1b Study in Patients With Advanced Malignancies
NCT04648202Advanced Cancer, Metastatic Cancer
invoX Pharma Limited
Phase 1
82
Barcelona, Madrid, Valencia
2020-11-18
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
68
L'Hospitalet de Llobregat, Barcelona, Madrid, Palma de Mallorca, Pamplona, Seville
2020-11-17
Active, closed
Eclipse Medical Ltd.
Not applicable
200
Valladolid, Madrid, Salamanca, Barcelona
2020-11-17
Active, closed
AstraZeneca
Phase 3
957
Barcelona, Madrid, Málaga, Ourense, Santander, Seville, Valencia
2020-11-17
Active, closed
UCB Biopharma SRL
Phase 1
19
Barcelona, Madrid, Pamplona
2020-11-16
Active, closed
Janssen Research & Development, LLC
Phase 1
136
Madrid, Málaga
2020-11-13
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Cadiz, Ferrol, Jerez de la Frontera, Madrid, Málaga, Pamplona, Seville, Valencia
2020-11-12
Active, closed
AstraZeneca
Phase 1/2
702
Barcelona, Madrid, Málaga, Pozuelo de Alarcón, Seville
2020-11-12
Active, closed
AbbVie
Phase 1
21
Barcelona, Madrid
2020-11-11
Recruiting
Vyxeos® With Clofarabine for Pediatric AML
NCT07156435Relapsed Pediatric AML, Refractory Pediatric AML
DrugClofarabine
Princess Maxima Center for Pediatric Oncology
Phase 1
25
Barcelona, Madrid
2020-11-06
Recruiting
Value of Screening and Treatment of SAHS in the Management of AF Ablation Candidates
NCT04606693Atrial Fibrillation Paroxysmal, Atrial Fibrillation, Persistent, Apnea Syndrome, Hypopnea Syndrome
Hospital San Carlos, Madrid
Not applicable
50
Madrid
2020-11-05
Recruiting
Meril Life Sciences Pvt. Ltd.
Not applicable
988
Palma de Mallorca, Las Palmas, Córdoba, Madrid, Valladolid
2020-11-04
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
281
Barcelona, Gijón, Granada, Madrid, Majadahonda, Pamplona, Salamanca, Seville
2020-11-03
Active, closed
Genmab
Phase 1/2
543
Barcelona, Madrid, Salamanca
2020-11-03
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
NCT04585750Advanced Solid Tumor, Advanced Malignant Neoplasm, Metastatic Cancer, Metastatic Solid Tumor
DrugsRezatapopt·Keytruda·Pembrolizumab
PMV Pharmaceuticals, Inc
Phase 1/2
300
Madrid, Barcelona, Rioja, Valencia
2020-10-29
Active, closed
Hoffmann-La Roche
Phase 3
985
A Coruña, Lleida, Pozuelo de Alarcón, Vigo, Barcelona, Cadiz, Madrid, Málaga
2020-10-26
Recruiting
Abbott Vascular Medical Device Registry
NCT04573660Acute Myocardial Infarction, Restenoses, Coronary, Coronary Artery Lesions, Venous Embolism
Abbott Medical Devices
Observational
3,784
Barcelona, Madrid, Alicante
2020-10-25
Active, closed
AstraZeneca
Phase 3
640
Barcelona, Córdoba, Madrid, Pamplona, Santander, Zaragoza
2020-10-19
Active, closed
Janssen Research & Development, LLC
Phase 3
308
A Coruña, Badalona, Barcelona, Burgos, Madrid, Majadahonda, Málaga, Pamplona
2020-10-13
Active, closed
Hoffmann-La Roche
Phase 3
992
L'Hospitalet de Llobregat, Donostia / San Sebastian, Pozuelo de Alarcón, A Coruña, Barcelona, Madrid, Seville, Valencia
2020-10-09
Active, closed
Acerta Pharma BV
Phase 3
611
Alcalá de Henares, Badalona, Barcelona, Gijón, L'Hospitalet de Llobregat, Madrid, Palma, Pamplona
2020-10-08
Active, closed
Hoffmann-La Roche
Phase 3
210
Bilbao, Badalona, Las Palmas de Gran Canaria, Barcelona, Cáceres, Madrid, Salamanca
2020-10-08
Active, closed
CARdiomyopathy in Type 2 DIAbetes Mellitus
NCT04303364Cardiomyopathy, Diabetic
Institut National de la Santé Et de la Recherche Médicale, France
Observational
1,256
Barcelona, Madrid
2020-10-02
Active, closed
AstraZeneca
Phase 3
370
Barcelona, Madrid, Valencia
2020-10-02
Active, closed
GlaxoSmithKline
Phase 3
302
Barcelona, Gijón, L'Hospitalet de Llobrega, Madrid, MOstoles Madrid, Murcia, Palma de Mallorca, PamplonaNavarra
2020-10-01
Active, closed
Eli Lilly and Company
Phase 1
200
Barcelona, Madrid
2020-10-01
Active, closed
Hoffmann-La Roche
Phase 3
190
Badalona, Santiago de Compostela, Asturias, Bilbao, Barcelona, Madrid, Málaga, Salamanca
2020-09-30
Active, closed
Mural Oncology, Inc
Phase 1/2
78
Madrid
2020-09-30
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
A Coruña, Badalona, Barcelona, Burgos, Girona, Madrid, Majadahonda, Málaga
2020-09-30
Active, closed
European Myeloma Network B.V.
Phase 3
302
Badalona, Barcelona, Madrid, Pamplona, Salamanca, Santander
2020-09-25
Active, closed
Ipsen
Phase 3
161
Barcelona, Madrid, Pontevedra, San Sebastián, Santander, Seville
2020-09-24
Active, closed
Janssen Research & Development, LLC
Phase 3
696
A Coruña, Barcelona, Castellon, Girona, Jerez de la Frontera, Madrid, Málaga, Sabadell
2020-09-23
Active, closed
argenx
Phase 2
229
Badalona, Barcelona, Madrid
2020-09-18
Recruiting
Pancreatic Cancer Early Detection Consortium
NCT04970056Pancreas Cancer, Pancreas Cyst, Pancreatic Ductal Adenocarcinoma, Genetic Predisposition
Arbor Research Collaborative for Health
Observational
20,000
Barcelona, Lleida, Madrid
2020-09-18
Active, closed
Janssen Research & Development, LLC
Phase 2
194
Badalona, Barcelona, Madrid, Pamplona, Pozuelo de Alarcón, Salamanca, Santander
2020-09-17
Recruiting
University of Birmingham
Phase 1/2
1,672
Barcelona, Bilbao, Madrid, Málaga, Seville, Valencia, Zaragoza
2020-09-17
Active, closed
ADC Therapeutics S.A.
Phase 3
440
Barcelona, Cáceres, Madrid, Santander, Seville, Valencia
2020-09-16
Active, closed
Daiichi Sankyo
Phase 1
145
Barcelona, Madrid, Majadahonda
2020-09-15
Recruiting
Epygenix
Phase 3
150
Madrid, Barcelona
2020-09-15
Recruiting
Rafael Correa-Rocha
Phase 1/2
11
Madrid
2020-09-10
Active, closed
AbbVie
Phase 3
531
Badalona, Córdoba, Pozuelo de Alarcón, Barcelona, Madrid, Salamanca, Seville, Valencia
2020-09-10
Active, closed
Hoffmann-La Roche
Phase 1/2
210
Argentona, Santiago de Compostela, A Gudiña, Las Cabezas de San Juan, Barcelona, Jaén, Madrid, Seville
2020-09-03
Active, closed
Karyopharm Therapeutics Inc
Phase 2/3
501
Badalona, Barcelona, Madrid, Seville
2020-09-03
Active, closed
Women's Cancer Study Group GmbH
Phase 3
1,260
Palma, Barcelona, Cáceres, Elche, Madrid, Manresa, Málaga, Pamplona
2020-09-02
Active, closed
AbbVie
Phase 3
330
A Coruña, Santiago de Compostela, Badalona, Las Palmas de Gran Canaria, Oviedo, Barcelona, Granada, Madrid
2020-08-31
Recruiting
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
NCT04421820Colorectal Cancer, Pancreatic Cancer, Gastric Cancers, Cholangiocarcinoma
DrugsFolfox·Oxaliplatin
Bold Therapeutics, Inc.
Phase 1/2
220
Barcelona, Madrid
2020-08-28
Active, closed
Philogen S.p.A.
Phase 2
98
Madrid, Málaga, San Cristóbal de La Laguna, San Sebastián, Valencia
2020-08-28
Active, closed
Prospective and Non-randomized Registry of CardioCel 3D
NCT04175327Intracardiac and Septal Defects, Valve and Anulus Repair, Great Vessel Reconstruction, Peripheral Vessel Reconstruction
LeMaitre Vascular
Observational
200
Madrid
2020-08-28
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
239
L'Hospitalet de Llobregat, Cáceres, Pozuelo de Alarcón, Marbella, Pamplona, Barcelona, Madrid, Pozuelo de Alarcon (madrid)
2020-08-20
Active, closed
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
NCT04482309Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer, Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
DrugTrastuzumab deruxtecan
AstraZeneca
Phase 2
477
Barcelona, Córdoba, Madrid, Valencia
2020-08-18
Active, closed
Hoffmann-La Roche
Phase 1/2
237
Madrid, Málaga
2020-08-12
Active, closed
Hoffmann-La Roche
Phase 3
271
Barcelona, Madrid
2020-08-10
Recruiting
Eisai Inc.
Phase 1/2
182
Badalona, Barcelona, Madrid, Toledo, Valencia
2020-08-06
Recruiting
AutoInflammatory Disease Alliance Registry (AIDA)
NCT05200715Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome, PFAPA Syndrome
University of Siena
Observational
3,500
Barakaldo, Barcelona, Madrid, Santander, Valencia
2020-08-06
Active, closed
MINIject Global Long-Term Follow-up Study
NCT04524416Open Angle Glaucoma, Ocular Hypertension
iSTAR Medical
Observational
116
Madrid
2020-08-05
Active, closed
MedImmune LLC
Phase 1
67
Barcelona, Córdoba, Madrid, Sabadell, Seville, Valencia
2020-08-05
Active, closed
AstraZeneca
Phase 3
185
Badalona, Barcelona, Córdoba, Donostia / San Sebastian, Granada, Madrid, Pamplona, Valencia
2020-08-04
Active, closed
Incyte Corporation
Phase 2
112
Alicante, Badalona, Barcelona, Boadilla del Monte, L'Hospitalet de Llobregat, Madrid, Pozuelo de Alarcón, Salamanca
2020-08-03
Active, closed
Medtronic
Observational
2,200
A Coruña, Granada, Madrid, Salamanca, Santa Cruz de Tenerife, Santiago, Valladolid
2020-08-01
Active, closed
Medtronic
Observational
2,200
A Coruña, Granda, Madrid, Salamanca, Santa Cruz de Tenerife, Santiago, Valladolid
2020-08-01
Recruiting
Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
NCT05040373Hereditary Transthyretin-mediated (hATTR) Amyloidosis, Polyneuropathy
Alnylam Pharmaceuticals
Observational
10
Madrid
2020-08-01
Active, closed
Genentech, Inc.
Phase 1
498
Barcelona, Madrid, Málaga, Seville, Valencia
2020-07-29
Active, closed
AstraZeneca
Phase 3
866
A Coruña, Barcelona, Córdoba, El Palmar, Madrid, San Sebastián, Seville, Valencia
2020-07-24
Active, closed
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
NCT04561362Urinary Bladder Neoplasm, Triple Negative Breast Neoplasms, Hormone Receptor Positive, HER2-negative Neoplasms, Hormone Receptor Positive, HER2-low Neoplasms
DrugsZelenectide pevedotin·Keytruda·Pembrolizumab
BicycleTx Limited
Phase 1/2
329
Barcelona, Madrid, Pozuelo de Alarcón, Santander
2020-07-17
Recruiting
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
NCT03651206Ovarian Carcinosarcoma, Endometrial Carcinosarcoma
DrugNiraparib
ARCAGY/ GINECO GROUP
Phase 2/3
138
Madrid, Murcia, Valencia
2020-07-15
Active, closed
Eisai Inc.
Phase 3
1,400
Barcelona, Donostia / San Sebastian, Madrid, Santander
2020-07-14
Active, closed
Celgene
Phase 2
276
Madrid, Salamanca, Seville
2020-07-14
Active, closed
GlaxoSmithKline
Phase 3
242
Barcelona, Madrid, Seville, Valencia
2020-07-14
Active, closed
AstraZeneca
Phase 3
1,012
Badalona (Barcelona), Barcelona, Las Palmas de Gran Canaria, Madrid, Oviedo, Santander, Seville
2020-07-13
Recruiting
Mats Heyman
Phase 3
6,430
Barakaldo, Barcelona, Esplugues de Llobregat, Madrid, Palma de Mallorca, Seville, Valencia, Zaragoza
2020-07-13
Active, closed
Baxalta now part of Shire
Observational
207
Palma de Mallorca, Barcelona, Las Palmas, Madrid, Málaga
2020-07-09
Active, closed
Amplatzer Amulet LAAO vs. NOAC
NCT04226547Atrial Fibrillation, Stroke, Bleeding
DrugNOAC
Abbott Medical Devices
Not applicable
2,650
Madrid, Barcelona, Salamanca
2020-07-07
Active, closed
Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia
NCT04258943Philadelphia Chromosome Positive CML, Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Chronic Phase Chronic Myelogenous Leukemia
DrugBosutinib
Children's Oncology Group
Phase 1/2
60
Barcelona, Madrid
2020-07-06
Active, closed
Sun Pharmaceutical Industries Limited
Phase 3
296
A Coruña, Córdoba, Madrid, Seville
2020-07-01
Active, closed
Actelion
Phase 3
935
Barcelona, Madrid, Málaga, Salamanca
2020-06-30
Active, closed
Sanofi
Phase 3
337
Barcelona, Pamplona, Valencia, Madrid, Salamanca, Zaragoza
2020-06-16
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Badalona, Barcelona, Madrid, Pamplona, Salamanca, Seville
2020-06-12
Active, closed
Eli Lilly and Company
Phase 1
71
Barcelona, Madrid
2020-06-11
Active, closed
Epizyme, Inc.
Phase 3
599
Barcelona, Marbella, El Palmar, Madrid, Pamplona, Salamanca, Seville
2020-06-11
Active, closed
GlaxoSmithKline
Phase 1/2
106
Badalona, Madrid, Pozuelo de AlarcOn Madr
2020-06-08
Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
NCT04389632Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma
DrugsSigvotatug vedotin·Keytruda·Cisplatin·Carboplatin
Seagen, a wholly owned subsidiary of Pfizer
Phase 1
1,006
Madrid, Elche, Santander, Barcelona, Jerez de la Frontera, Málaga
2020-06-08
Active, closed
Coronary Laser in Undilatable or Uncrossable Lesions
NCT07206082Coronary Artery Disease, Calcified Coronary Artery Disease, In Stent Restenosis, Chronic Total Occlusion (CTO)
Hospital Universitario La Paz
Observational
230
Madrid
2020-06-05
Active, closed
AstraZeneca
Phase 2
452
Barcelona, Madrid, Santander, Seville
2020-06-03
Recruiting
SUCCESS Score Validation in Fuchs Dystrophy
NCT07265388Fuchs Endothelial Corneal Dystrophy
Instituto Ramón y Cajal de Investigación Sanitaria
Observational
250
Madrid
2020-06-01
Active, closed
Long-Term Follow-up of Subjects With Fanconi Anaemia Subtype A Treated With ex Vivo Gene Therapy
NCT04437771Fanconi Anemia Complementation Group A, Fanconi Anemia
Rocket Pharmaceuticals Inc.
Observational
9
Madrid
2020-06-01
Active, closed
AstraZeneca
Phase 3
805
Barcelona, El Palmar, Girona, Jaén, Madrid, Mallorca
2020-05-05
Active, closed
First in Men Study: BIOMAG-I
NCT04157153Coronary Artery Disease
Biotronik AG
Not applicable
116
Madrid
2020-04-27
Active, closed
AstraZeneca
Phase 2
240
Barcelona, Madrid, Seville, Zaragoza
2020-04-22
Active, closed
AstraZeneca
Phase 3
818
A Coruña, Barcelona, Córdoba, Hosp de Llobregat(Barcelona), Jaén, La Laguna (Tenerife), Lleida, Madrid
2020-04-16
Active, closed
Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)
NCT04184050Multiple Myeloma in Relapse, Multiple Myeloma, Multiple Myeloma of Bone, Multiple Myeloma With Failed Remission
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 1
100
Barcelona, Madrid
2020-04-13
Recruiting
Proton Therapy Medical Registry
NCT05151952Cancer, Therapy-Related
Clinica Universidad de Navarra, Universidad de Navarra
Observational
6,000
Pamplona, Madrid
2020-04-01
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Barcelona, Córdoba, Lugo, Madrid, Manresa, Pamplona, Sabadell, Santander
2020-03-30
Active, closed
BeOne Medicines
Phase 1
437
Barcelona, Madrid, Salamanca, Santander
2020-03-24
Recruiting
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
NCT04094610Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma, Primary CNS Tumors
DrugRepotrectinib
Turning Point Therapeutics, Inc.
Phase 1/2
75
Esplugues de Llobregat, Pamplona, Barcelona, Madrid, Seville, Valencia
2020-03-12
Active, closed
First-in-Human Study of ICT01 in Patients With Advanced Cancer
NCT04243499Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer
ImCheck Therapeutics, an Ipsen company
Phase 1/2
293
Barcelona, Madrid
2020-03-05
Recruiting
Amgen
Phase 1
479
Barcelona, Pamplona, Madrid
2020-03-04
Active, closed
Merck Sharp & Dohme LLC
Phase 3
755
Barcelona, Valencia, Madrid
2020-02-27
Active, closed
Amgen
Phase 3
145
Granada, Seville, Salamanca, Barcelona, Ourense, Fuenlabrada, Castellon, Madrid
2020-02-26
Active, closed
Immunocore Ltd
Phase 1/2
410
Pamplona, Barcelona, Madrid
2020-02-25
Active, closed
Janssen Research & Development, LLC
Phase 1
290
Barcelona, Madrid, Pamplona, Salamanca
2020-02-21
By invitation
Global Utilization And Registry Database for Improved heArt preservatioN
NCT04141605Heart Diseases, Heart Failure, Heart Defects, Congenital
Paragonix Technologies
Observational
3,000
Madrid, Valladolid
2020-02-14
Active, closed
Eli Lilly and Company
Phase 3
58
Esplugues de Llobregat, Madrid, Seville, Valencia
2020-02-12
Active, closed
Loxo Oncology, Inc.
Phase 3
291
Barcelona, L'Hospitalet de Llobregat, Girona, Madrid, Málaga, Pamplona, Zaragoza
2020-02-11
Active, closed
Daiichi Sankyo
Phase 1
115
A Coruña, Barcelona, Las Palmas de Gran Canaria, Madrid, Seville, Zaragoza
2020-02-10
Recruiting
Technical University of Madrid
Not applicable
84
Santander, Madrid
2020-02-03
Active, closed
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Observational
120
Madrid
2020-01-30
Recruiting
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
NCT03934372Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia
DrugPonatinib
Incyte Biosciences International Sàrl
Phase 1/2
70
Barcelona, Madrid, Valencia
2020-01-29
Active, closed
Hoffmann-La Roche
Phase 2/3
325
Badalona, Pamplona, San Cristóbal de La Laguna, Barcelona, Jaén, Madrid, Seville, Valencia
2020-01-29
Recruiting
Eli Lilly and Company
Phase 2
105
Barcelona, Esplugues de Llobregat, Madrid, San Cristóbal de La Laguna, Seville, Valencia
2020-01-22
Active, closed
BeOne Medicines
Phase 3
955
Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Salamanca, Toledo
2020-01-16
Active, closed
Actelion
Phase 3
138
A Coruña, Barcelona, Esplugues de Llobregat, Madrid, Seville
2020-01-16
Active, closed
Takeda
Phase 3
354
L'Hospitalet de Llobregat, A Coruña, Alicante, Barcelona, Córdoba, Madrid, Valencia
2020-01-10
Active, closed
Advanced Accelerator Applications
Phase 3
226
Barcelona, Madrid, Valencia
2020-01-08
Active, closed
Institut de Recherches Internationales Servier
Phase 3
331
Barcelona, Madrid
2020-01-05
Recruiting
Universidad Europea de Madrid
Not applicable
80
Madrid
2020-01-01
Active, closed
USWM CT, LLC
Phase 2
103
Barcelona, Hospitalet de Llobregat, Barcelona, Madrid, Seville
2019-12-31
Active, closed
Galderma R&D
Phase 3
1,700
Alicante, Barcelona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Pamplona
2019-12-30
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 1
161
Barcelona, Madrid, Valencia
2019-12-20
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Barcelona, Girona, Lleida, Madrid, Palma, Tarragona, Valencia
2019-12-20
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
450
L'Hospitalet de Llobregat, Madrid
2019-12-19
Recruiting
Merck Sharp & Dohme LLC
Observational
1,065
L'Hospitalet de Llobregat, Barcelona, Madrid
2019-12-19
Active, closed
GlaxoSmithKline
Phase 1
118
Badalona, Barcelona, Madrid, Málaga, PamplonaNavarra, Pozuelo de AlarcOn Madr, Santander
2019-12-18
Active, closed
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
NCT04185883Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation
DrugsBI 1701963·TNO155·Sotorasib·Afatinib
Amgen
Phase 1
610
Barcelona, L'Hospitalet de Llobregat, Majadahonda, Madrid
2019-12-17
Active, closed
SOLTI Breast Cancer Research Group
Not applicable
180
Badalona, Barcelona, Jerez de la Frontera, Santa Cruz de Tenerife, Lleida, Madrid, Seville, Valencia
2019-12-13
Active, closed
Cold Agglutinin Disease Real World Evidence Registry
NCT05791708Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS)
RECORDATI GROUP
Observational
429
Barcelona, Madrid
2019-12-12
Active, closed
A Clinical Trial Evaluating TG4050 in Head and Neck Cancer
NCT04183166Squamous Cell Carcinoma of Head and Neck
Transgene
Phase 1/2
80
Barcelona, Madrid, Málaga, Santiago de Compostela
2019-12-12
Active, closed
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
NCT04188548Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, Endometrial Cancer
DrugsImlunestrant·Alpelisib·Everolimus·Abemaciclib
Eli Lilly and Company
Phase 1
379
Barcelona, Madrid, Valencia
2019-12-10
Active, closed
LAM561 With RT and TMZ for Adults With Glioblastoma
NCT04250922Primary Glioblastoma, Glioblastoma Multiforme
DrugLAM561
Laminar Pharmaceuticals
Phase 2/3
144
Córdoba, Seville, Barcelona, Madrid, Valencia, Sabadell
2019-12-01
Active, closed
GlaxoSmithKline
Phase 2
25
Barcelona, Madrid, Valencia
2019-11-28
Recruiting
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
NCT04071847Movement Disorders, Parkinson Disease, Essential Tremor, Tremor
Abbott Medical Devices
Observational
1,000
Seville, Badalona, Madrid
2019-11-26
Active, closed
Gilead Sciences
Phase 2/3
72
Badalona, Barcelona, Madrid, Seville
2019-11-21
Active, closed
ETOP IBCSG Partners Foundation
Phase 2
96
Barcelona, Granada, Madrid, Valencia
2019-11-19
Active, closed
Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia
NCT04232241Acute Myeloid Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission, Myelodysplastic Syndromes
Universitätsklinikum Hamburg-Eppendorf
Phase 2
167
Badalona, Barcelona, Madrid, Salamanca, Seville, Valencia
2019-11-14
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
Palma, Barcelona, Pozuelo de Alarcón, Madrid, Salamanca, Valencia
2019-11-13
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Madrid, Málaga, Oviedo, Seville, Valencia
2019-11-13
Active, closed
Inotrem
Phase 2
355
Barcelona, Madrid, Oviedo, Terrassa, Valencia
2019-11-13
Active, closed
Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
NCT04140500Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer, Esophageal Squamous Cell Carcinoma
DrugTobemstomig
Hoffmann-La Roche
Phase 1/2
170
Pamplona, Barcelona, Madrid
2019-11-11
Active, closed
AbbVie
Phase 1
85
L'Hospitalet de Llobregat, Pamplona, Madrid
2019-11-08
Active, closed
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
NCT04180371Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer, Non-small Cell Lung Cancer
DrugsNuzefatide pevedotin·Opdivo·Nivolumab
BicycleTx Limited
Phase 1/2
288
Barcelona, Madrid
2019-11-07
Active, closed
AbbVie
Phase 1/2
218
Madrid, Valencia
2019-11-06
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
DrugsDinutuximab Beta·Vindesine·Cyclophosphamid·Thiotepa
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
800
Balea, Barcelona, Cruces, El Palmar, Madrid, Málaga, San Sebastián, Santiago de Compostela
2019-11-05
Active, closed
Bristol-Myers Squibb
Phase 3
461
Madrid, Majadahonda - Madrid, Valencia
2019-11-05
Active, closed
Pediatric Long-Term Follow-up and Rollover Study
NCT03975829Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood
DrugsDabrafenib·Trametinib
Novartis Pharmaceuticals
Phase 4
163
Madrid, Valencia
2019-11-04
Active, closed
Balt Extrusion
Observational
234
Barakaldo, Madrid, Oviedo, Valladolid
2019-11-04
Active, closed
Orbital Fractures Registry
NCT03887988Orbital Fractures, Blow Out Fracture of Orbit
AO Innovation Translation Center
Observational
300
Barcelona, Madrid
2019-11-01
Active, closed
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer
NCT04036682Non Small Cell Lung Cancer, EGFR Exon 20 Mutation
DrugZipalertinib
Cullinan Therapeutics Inc.
Phase 1/2
284
A Coruña, Barcelona, Las Palmas, Madrid, Málaga, Pamplona, Valencia
2019-10-31
Active, closed
Novartis Pharmaceuticals
Phase 1
120
L'Hospitalet de Llobregat, Barcelona, Madrid, Valencia
2019-10-30
Active, closed
Bristol-Myers Squibb
Phase 3
790
Barcelona, A Coruña, Badalona, Madrid, Málaga, Santander, Valencia
2019-10-28
Recruiting
GlaxoSmithKline
Phase 1/2
184
BaracaldoVizcaya, Espluges de Llobregat, HebrOn, Madrid, Seville
2019-10-25
Active, closed
Canadian Cancer Trials Group
Phase 2
82
Barcelona, Madrid, Santander, Valencia
2019-10-25
Active, closed
Nouscom SRL
Phase 1/2
115
A Coruña, Barcelona, Córdoba, Granada, Madrid, Pamplona, Salamanca, Santander
2019-10-21
Active, closed
Novo Nordisk A/S
Phase 3
134
Barcelona, Madrid, Málaga, Oviedo, Seville
2019-10-21
Active, closed
Biogen
Phase 3
152
Esplugues de Llobregat, El Palmar, Córdoba, Madrid
2019-10-18
Active, closed
Replimune, Inc.
Phase 1
36
Barcelona, Madrid, Valencia
2019-10-17
Active, closed
Eli Lilly and Company
Phase 3
30
Esplugues de Llobregat, Madrid, Valencia
2019-10-16
Active, closed
Gilead Sciences
Phase 2
227
Barcelona, Madrid, Valencia
2019-10-15
Recruiting
Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry
NCT03991728Temporomandibular Joint Disorders
AO Innovation Translation Center
Observational
200
Madrid
2019-10-15
Active, closed
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
NCT04050436Cutaneous Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma
DrugsVusolimogene Oderparepvec·Cemiplimab
Replimune, Inc.
Phase 2
231
Barcelona, Madrid, Murcia, Pamplona, Valencia
2019-10-08
Active, closed
PULSTA Transcatheter Pulmonary Valve Pre-Approval Study
NCT03983512Heart Diseases, Pulmonary Valve Regurgitation, Pulmonary Valve Stenosis, Tetralogy of Fallot
Taewoong Medical Co., Ltd.
Not applicable
58
Madrid
2019-10-07
Active, closed
GlaxoSmithKline
Phase 1/2
208
Badalona, Madrid, PamplonaNavarra, Pozuelo de AlarcOn Madr
2019-10-07
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Badajoz, Barcelona, Madrid, Málaga, Salamanca
2019-10-03
Recruiting
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
NCT03955445C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis
DrugIptacopan
Novartis Pharmaceuticals
Phase 3
225
Pamplona, Barcelona, Madrid, Seville
2019-10-03
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
466
Palma de Mallorca, Barcelona, San Cristóbal de La Laguna, Córdoba, Madrid, Sant Joan Despí, Seville, Valencia
2019-10-02
Active, closed
NeuroDerm Ltd.
Phase 3
381
Oviedo, Alicante, Barcelona, Burgos, Madrid, Seville, Valencia
2019-09-30
Active, closed
Celgene
Phase 1/2
424
Badalona, Madrid, Málaga, Pamplona, Salamanca, Santander, Valencia
2019-09-30
By invitation
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
NCT04093570Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes
DrugDecitabine
Taiho Oncology, Inc.
Phase 2
332
Lleida, Madrid, Murcia, Valencia
2019-09-30
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Badalona, Barcelona, Girona, Madrid, Santander, Seville
2019-09-26
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Barcelona, Madrid, Valencia
2019-09-23
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
NCT04104776Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant
DrugsTulmimetostat·Enzalutamide
Novartis Pharmaceuticals
Phase 1/2
300
Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Majadahonda, Palma, Pamplona, Sabadell
2019-09-18
Active, closed
Spanish Oncology Genito-Urinary Group
Phase 2
39
Manresa, Sabadell, Reus, Granada, Lugo, Madrid, Ourense, Oviedo
2019-09-18
Recruiting
Stroke Thrombectomy and Aneurysm Registry
NCT04994756Stroke, Thromboses, Intracranial, Aneurysm, Brain
Medical University of South Carolina
Observational
40,000
Madrid
2019-09-17
Active, closed
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
NCT04083599Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Melanoma
DrugsGEN1042·Adrucil·Nab-paclitaxel·Pemetrexed
Genmab
Phase 1/2
350
Barcelona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Lugo, Madrid, Málaga, Pamplona, Santiago de Compostela
2019-09-17
Active, closed
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
NCT03992404Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury
DrugXeomin
Merz Pharmaceuticals GmbH
Phase 3
603
Huelva, Madrid, Terrassa
2019-09-16
Active, closed
MedImmune LLC
Phase 1/2
61
Barcelona, Madrid
2019-09-13
Active, closed
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
NCT04067336Advanced Malignant Neoplasm, Acute Myeloid Leukemia, Mixed Lineage Leukemia, Mixed Lineage Acute Leukemia
DrugsZiftomenib·Itraconazole·Midazolam
Kura Oncology, Inc.
Phase 1/2
263
Barcelona, Madrid, Oviedo, Seville, Valencia
2019-09-12
Active, closed
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
NCT03844048Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma
DrugsVenclexta·Venetoclax
AbbVie
Phase 3
165
Madrid
2019-09-06
Active, closed
Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET
NCT03993873Advanced Solid Tumor, Metastatic Solid Tumors, MET Gene Alterations
Turning Point Therapeutics, Inc.
Phase 1
95
Madrid, Pamplona
2019-09-05
Active, closed
Pfizer
Phase 3
896
Alicante, Madrid
2019-09-05
Active, closed
Janssen Research & Development, LLC
Phase 1
701
Barcelona, Madrid, Seville
2019-09-04
Recruiting
Mats Heyman
Observational
500
Alicante, Barakaldo, Barcelona, Fuencarral-El Pardo, Madrid, Murcia, Palma de Mallorca, Santander
2019-08-29
Active, closed
ETOP IBCSG Partners Foundation
Phase 3
405
San Cristóbal de La Laguna, A Coruña, Alicante, Barcelona, Bilbao, Girona, Madrid, Málaga
2019-08-27
Recruiting
Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
NCT04832607AdV Infection, EBV Infection, CMV Infection, Stem Cell Transplant Complications
Tobias Feuchtinger
Phase 3
149
Barcelona, Madrid, Seville, Valencia
2019-08-27
Active, closed
ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)
NCT04044859Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ), Gastric (Stomach) Cancer
USWM CT, LLC
Phase 1
120
Madrid, Pío, Ibanez, Barcelona, Seville
2019-08-20
Active, closed
BeOne Medicines
Phase 3
510
Barcelona, Girona, Madrid, Málaga, Seville
2019-08-20
Active, closed
Sanofi
Observational
1,860
Barcelona, Pozuelo de Alarcón, Mieres, Madrid
2019-08-15
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Alcalá de Henares, Badalona, Barcelona, Burgos, Córdoba, Las Palmas de Gran Canaria, Madrid, Majadahonda
2019-08-15
Active, closed
USWM CT, LLC
Phase 2
52
Barcelona, Madrid, Seville
2019-08-13
Active, closed
Hoffmann-La Roche
Phase 1/2
498
Barcelona, Madrid, Málaga
2019-08-13
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
Barakaldo, Barcelona, Madrid, Oviedo, Salamanca, Seville, Valencia
2019-08-12
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Pozuelo de Alarcón, El Palmar, Vigo, Barcelona, Madrid, Salamanca, Seville, Valencia
2019-08-12
Recruiting
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
NCT04068597Haematological Malignancy, Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma
DrugsIxazomib·Elranatamab·Teclistamab·Pomalidomide
CellCentric Ltd.
Phase 1/2
250
Badalona, Barcelona, Madrid, Pamplona, Valencia
2019-08-09
Active, closed
Bristol-Myers Squibb
Phase 3
839
Badalona, A Coruña, Barcelona, Madrid, Málaga, Seville, Valencia
2019-08-05
Recruiting
Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
NCT03711110Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Elderly, Antineoplastic Agents, Cardiotoxicity
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Not applicable
514
Santiago de Compostela, Galdakao, Barcelona, Córdoba, Madrid, Málaga, Salamanca, Seville
2019-08-02
Active, closed
OncoVerity, Inc.
Phase 2
103
Pozuelo de Alarcón, Barcelona, Córdoba, Madrid, Palma, Salamanca, Valencia
2019-07-29
Active, closed
Novartis Pharmaceuticals
Phase 3
254
Barcelona, Madrid
2019-07-26
Recruiting
Oxford BioTherapeutics Ltd
Phase 1
200
Barcelona, Madrid, Santander
2019-07-25
Active, closed
Edwards Lifesciences
Observational
150
Madrid
2019-07-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Badalona, Barcelona, Cáceres, Girona, Pozuelo de Alarcón, Valencia, Madrid, Seville
2019-07-24
Active, closed
Tesaro, Inc.
Phase 3
785
Barcelona, Donostia / San Sebastian, Madrid, Málaga, Murcia, Valencia
2019-07-18
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
197
Badalona, Madrid, Pamplona, Valencia
2019-07-17
Active, closed
Consorzio Futuro in Ricerca
Not applicable
1,445
A Coruña, Ciudad Real, Lugo, Madrid, Santiago de Compostela, Valencia, Valladolid, Vigo
2019-07-15
Active, closed
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
NCT04008797Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms
DrugsE7386·Doxorubicin·Lenvatinib·Paclitaxel
Eisai Inc.
Phase 1/2
301
A Coruña, Barcelona, Jaén, Madrid
2019-07-11
Active, closed
Dizal Pharmaceuticals
Phase 1/2
315
Barcelona, Girona, Jerez de la Frontera, Madrid, Málaga, Seville, Valencia
2019-07-09
Active, closed
Infant Bacterial Therapeutics
Phase 3
2,158
Alicante, Madrid, Tarragona, Valencia
2019-07-04
Recruiting
Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK
NCT04181970Soft-tissue Sarcoma, Gastrointestinal Stromal Tumors, Bone Sarcoma
Grupo Espanol de Investigacion en Sarcomas
Observational
5,000
Madrid
2019-06-30
Active, closed
Grupo Español de Investigación en Cáncer de Ovario
Phase 2
134
Elche, Donostia / San Sebastian, Girona, Madrid, Vigo, Seville, Valencia, Barcelona
2019-06-28
Active, closed
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
NCT03960840Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia
DrugIbrutinib
Novartis Pharmaceuticals
Phase 1/2
217
Badalona, L'Hospitalet de Llobregat, Barcelona, Córdoba, Madrid, Salamanca, Seville, Valencia
2019-06-26
Active, closed
AstraZeneca
Phase 2
247
A Coruña, Barcelona, Madrid, Seville
2019-06-25
Active, closed
AstraZeneca
Phase 3
923
Badalona, Barcelona, Hospitalet deLlobregat, Jaén, Madrid, Málaga, Seville, Valencia
2019-06-25
Active, closed
Exelixis
Phase 3
855
Santiago de Compostela, Pamplona, Barcelona, Córdoba, Madrid, Oviedo, Valencia
2019-06-25
Active, closed
AbbVie
Phase 1
124
Esplugues de Llobregat, Madrid, Valencia
2019-06-24
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
2,000
Badalona, Barcelona, Cartagena, Córdoba, Madrid, Pamplona, Salamanca, Terrassa
2019-06-24
Active, closed
Bristol-Myers Squibb
Phase 3
437
Barcelona, Córdoba, Madrid, Pamplona, Sabadell, Santander, Santiago Compostela, Seville
2019-06-21
Recruiting
Population Health Research Institute
Phase 4
2,270
Barcelona, Madrid, Pamplona
2019-06-14
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
366
Barcelona, Lleida, Madrid, Reus, Seville, Valencia
2019-06-14
Active, closed
Sanofi
Observational
955
Bilbao, Las Palmas de Gran Canaria, Majadahonda, Oviedo, Barakaldo, Barcelona, Madrid, Santiago de Compostela
2019-06-11
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
A Coruña, Barcelona, Cadiz, Castellon, Jerez de la Frontera, Madrid, Manacor, Málaga
2019-06-11
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Barcelona, Alcorcón, Torrejón de Ardoz, Badalona, Madrid, Majadahonda, Salamanca, Seville
2019-06-04
Active, closed
Eisai Inc.
Phase 2
100
Madrid, Pamplona, Santiago de Compostela, Seville
2019-05-31
Active, closed
AbbVie
Phase 1
150
Barcelona, Madrid, Málaga
2019-05-21
Active, closed
Celgene
Phase 1/2
438
Badalona (Barcelona), Barcelona, Madrid, Málaga, Salamanca
2019-05-20
Active, closed
Javelin Medical
Not applicable
100
Madrid
2019-04-15
Recruiting
Eli Lilly and Company
Phase 3
190
Esplugues de Llobregat, Madrid, Seville, Valencia
2019-04-05
Recruiting
AstraZeneca
Phase 3
140
Esplugues de Llobregat, Madrid
2019-04-02
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Majadahonda, Almería, Barcelona, Madrid, Pontevedra, Santander, Seville, Valencia
2019-03-28
Active, closed
Effectiveness of Treatments for Massive Rotator Cuff Tears: Mixed Methodology.
NCT05780229Massive Rotator Cuff Tears, Shoulder Disease
Parc de Salut Mar
Observational
200
Sabadell, Barcelona, Madrid
2019-03-27
Active, closed
Eisai Inc.
Phase 3
1,906
Sant Cugat del Vallès, Getxo, Donostia / San Sebastian, Barcelona, Córdoba, Madrid, Salamanca, Seville
2019-03-27
Active, closed
AbbVie
Phase 3
964
Badalona, Sabadell, A Coruña, Almería, Barcelona, Madrid, Valencia
2019-03-25
Active, closed
Avelumab Program Rollover Study
NCT03815643Solid Tumors
DrugAvelumab
EMD Serono Research & Development Institute, Inc.
Phase 3
205
Barcelona, Madrid, Mataró
2019-03-22
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Alicante, Badalona, Barcelona, Córdoba, L'Hospitalet de Llobregat, Madrid, Santander, Seville
2019-03-21
Active, closed
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
NCT03845166Neoplasm Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer
DrugsZanzalintinib·Avelumab·Tecentriq·Atezolizumab
Exelixis
Phase 1
325
Sabadell, Santiago de Compostela, Barcelona, Madrid, Seville
2019-03-20
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
DrugsZolbetuximab·Nab-paclitaxel·Gemcitabine
Astellas Pharma Global Development, Inc.
Phase 2
393
Llobregat, Pamplona, Barcelona, Cáceres, Córdoba, Lleida, Madrid, Málaga
2019-03-15
Active, closed
Durvalumab and Tremelimumab for Pediatric Malignancies
NCT03837899Pediatric Cancer, Solid Tumor Pediatric, Hematological Malignancies
DrugDurvalumab
AstraZeneca
Phase 1/2
50
Barcelona, Madrid
2019-03-07
Active, closed
AstraZeneca
Phase 3
724
Badajoz, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, San Sebastián, Santiago de Compostela, Seville
2019-03-06
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Barcelona, Girona, Madrid, Palma, Tarragona, Valencia
2019-03-01
Active, closed
Hoffmann-La Roche
Phase 3
1,000
Barcelona, Madrid
2019-02-28
Recruiting
Escuela Universitaria de Fisioterapia de la Once
Observational
22
Madrid
2019-02-27
Active, closed
Acerta Pharma BV
Phase 3
984
Badalona, Barcelona, Madrid, Majadahonda, Salamanca, Santander, Valencia
2019-02-25
Active, closed
Follow-up in Gynecological Cancer Survivors
NCT03515993Gynecologic Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Observational
1,100
Madrid, Pamplona, Salamanca
2019-02-21
Active, closed
AbbVie
Phase 1
364
Pamplona, Barcelona, Madrid, Valencia
2019-02-21
Active, closed
NVT GmbH
Observational
346
Madrid, Málaga, Salamanca, Vigo
2019-02-20
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
453
Barcelona, Bilbao, Madrid, Málaga, Seville, Valencia, Vigo
2019-02-08
Recruiting
Guillermo Galeote; MD, PhD
Not applicable
124
Madrid
2019-02-02
Active, closed
Xenon Pharmaceuticals Inc.
Phase 2
325
Seville, Badalona, Pamplona, Barcelona, Granada, Madrid, Málaga, Valencia
2019-01-30
Active, closed
Janssen Research & Development, LLC
Phase 3
765
A Coruña, Barcelona, Jerez de la Frontera, Madrid, Málaga, Pozuelo de Alarcón, Sabadell, Santander
2019-01-25
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
387
Barcelona, Pamplona, Madrid, Salamanca
2019-01-23
Active, closed
UNICANCER
Phase 3
517
A Coruña, Cadiz, Madrid, Murcia, Santa Cruz de Tenerife
2019-01-17
Recruiting
RECORDATI GROUP
Observational
95
Barcelona, Bilbao, Madrid, Murcia, Palma de Mallorca, Seville, Zaragoza
2019-01-15
Active, closed
AstraZeneca
Phase 2
367
Córdoba, Donostia / San Sebastian, Madrid, Málaga, Valencia, Zaragoza
2019-01-09
Active, closed
9-ING-41 in Patients With Advanced Cancers
NCT03678883Cancer, Pancreatic Cancer, Sarcoma, Renal Cancer
DrugsCCNU·Lomustine·Abraxane·Adriamycin
Actuate Therapeutics Inc.
Phase 2
350
Barcelona, Madrid, Valencia
2019-01-04
Active, closed
AstraZeneca
Phase 3
1,407
Córdoba, Madrid, Terrassa(Barcelona), Vigo
2019-01-04
Active, closed
Celgene
Phase 3
363
Barcelona, Granada, Madrid, Málaga, Murcia, Ourense, Oviedo, Palma de Mallorca
2019-01-02
Active, closed
The European Robotic Spinal Instrumentation (EUROSPIN) Study
NCT03398915Degenerative Disc Disease, Spondylolisthesis, Spinal Stenosis, Recurrent Disc Herniation
Marc Schröder
Observational
932
Madrid
2019-01-01
Recruiting
Fundación Academia Española de Dermatología
Observational
2,500
Badalona, Alicante, Barcelona, Las Palmas, Madrid, Pontevedra, Valencia, Zaragoza
2019-01-01
Active, closed
AstraZeneca
Phase 1
175
Barcelona, Madrid, Seville
2018-12-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,240
L'Hospitalet de Llobregat, A Coruña, Pozuelo de Alarcón, Madrid, Valencia, Barcelona, Jaén, Seville
2018-12-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Lugo, Pozuelo de Alarcón, Pamplona, Barcelona, Madrid, Valencia
2018-12-24
Active, closed
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
NCT03661866Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo
Target PharmaSolutions, Inc.
Observational
15,000
Barcelona, Madrid
2018-12-21
Active, closed
Idorsia Pharmaceuticals Ltd.
Phase 3
107
Barcelona, Madrid, Zaragoza
2018-12-18
Active, closed
Resorbable vs Non-resorbable Bone Substitute at Immediate Post-extractive Single Implants
NCT07047131Tooth Extraction, Bone Graft, Alveolar Bone Loss, Dental Implant
Marco Esposito
Phase 3
50
Madrid
2018-12-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
714
Badalona, L'Hospitalet de Llobregat, Santiago de Compostela, Barcelona, Madrid, Seville
2018-12-17
Active, closed
Travere Therapeutics, Inc.
Phase 3
406
Palma de Mallorca, Sagunto, Barcelona, Madrid, Seville, Valencia, Zaragoza
2018-12-11
Active, closed
AstraZeneca
Phase 3
825
Alicante, Barcelona, Donostia / San Sebastian, Madrid, Málaga, Oviedo, Pamplona, Santiago de Compostela (A Coruña)
2018-12-06
By invitation
IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry
NCT04520347Ventricular Arrhythmia, Ventricular Tachycardia, Premature Ventricular Contraction (PVC), Cardiomyopathy
University of California, Los Angeles
Observational
10,000
Madrid
2018-12-01
Active, closed
AstraZeneca
Phase 3
724
Córdoba, Madrid, Pamplona, San Sebastián(Guipuzcoa)
2018-11-30
Active, closed
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
507
A Coruña, Barcelona, Elche, Madrid, Málaga, Pamplona, Valencia
2018-11-28
Active, closed
Eli Lilly and Company
Phase 2/3
393
Barcelona, Hospitalet, Madrid, Málaga
2018-11-26
Active, closed
AstraZeneca
Phase 3
1,063
Badalona, Barcelona, Córdoba, Las Palmas de Gran Canaria, Madrid, Santander, Seville
2018-11-16
Recruiting
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
NCT03563417Ischemic Heart Disease, Chronic Total Occlusion of Coronary Artery
Aarhus University Hospital Skejby
Not applicable
1,560
Badalona, Galdakao, Barcelona, Madrid, Tarragona
2018-11-06
Active, closed
AstraZeneca
Phase 3
895
Barcelona, Girona, Madrid, Málaga, Seville
2018-10-31
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Barakaldo, Barcelona, Madrid, Málaga, Seville
2018-10-29
Active, closed
AbbVie
Phase 3
265
Palma de Mallorca, Marbella, Ourense, San Cristóbal de La Laguna, Barcelona, Girona, León, Madrid
2018-10-22
Active, closed
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Phase 3
419
Madrid
2018-10-15
Active, closed
AstraZeneca
Phase 1
396
Barcelona, Madrid, Seville, Valencia
2018-10-11
Active, closed
Tesaro, Inc.
Phase 3
1,400
Ávila, Badalona, Barcelona, Girona, Jaén, Madrid, Santiago de Compostela, Toledo
2018-10-11
Active, closed
AbbVie
Phase 2
270
Santiago de Compostela, Badalona, Las Palmas de Gran Canaria, Alcorcón, Ávila, Barcelona, Madrid, Málaga
2018-10-10
Recruiting
Inhibrx Biosciences, Inc
Phase 1
411
Barcelona, Madrid
2018-10-08
Active, closed
Exelixis
Phase 3
187
Barcelona, Madrid, Málaga
2018-10-05
Active, closed
AstraZeneca
Phase 3
730
Barcelona, Madrid, Oviedo, Seville, Valencia, Zaragoza
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,246
Barcelona, Lugo, Madrid, Málaga, Santander, Seville
2018-09-27
Active, closed
Hoffmann-La Roche
Phase 1/2
422
Barcelona, Cáceres, Madrid, Seville
2018-09-25
Recruiting
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
NCT03567889Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID
DrugDaromun
Philogen S.p.A.
Phase 3
186
Badalona, Barcelona, Las Palmas de Gran Canaria, Donostia / San Sebastian, Madrid, Málaga, Murcia, Seville
2018-09-20
Active, closed
V-Wave Ltd
Not applicable
605
Barcelona, Madrid, Valencia, Valladolid
2018-09-19
Recruiting
Registry of Catheter Intervention in Pulmonary Embolism
NCT06348459Pulmonary Embolism, Pulmonary Embolism Acute Massive, Pulmonary Embolism Acute, Pulmonary Embolism and Thrombosis
Hospital San Carlos, Madrid
Observational
300
Madrid
2018-09-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Donostia / San Sebastian, Valencia, Barcelona, Madrid, Seville
2018-09-12
Active, closed
Marc van Sambeek
Observational
156
Madrid, Ourense
2018-09-11
Active, closed
AbbVie
Phase 3
1,242
Ferrol, Sabadell, Majadahonda, Vigo, Gijón, Barcelona, Córdoba, Madrid
2018-08-28
Active, closed
Xynomic Pharmaceuticals, Inc.
Phase 2
139
Donostia / San Sebastian, Barcelona, Córdoba, Madrid
2018-08-27
Active, closed
Hoffmann-La Roche
Phase 3
257
Barcelona, Madrid, Seville, Valencia
2018-08-16
Active, closed
Daiichi Sankyo
Phase 1/2
65
Madrid
2018-08-15
Active, closed
Gilead Sciences
Phase 2
502
Badalona, Barcelona, Córdoba, Las Palmas, Madrid, Majadahonda, Manresa, Ourense
2018-08-13
Active, closed
AbbVie
Phase 3
1,533
Puerto Real, Alicante, Barcelona, Madrid
2018-08-09
Recruiting
Sanofi
Phase 2
51
Esplugues de Llobregat, Barcelona, Madrid, Málaga, Valencia
2018-08-09
Active, closed
AstraZeneca
Phase 3
216
Barcelona, Madrid, Málaga, San Sebastián, Seville, Valencia
2018-07-19
Recruiting
Celgene
Phase 2/3
1,541
Barcelona, Córdoba, Esplugues de Llobregat, Madrid, Málaga, Pamplona, Salamanca, Santander
2018-07-19
Active, closed
Eli Lilly and Company
Phase 3
1,058
Alicante, Fuenlabrada, Girona, Huelva, Las Palmas de GC, Madrid, Oviedo, Sagunto
2018-07-18
Recruiting
Xynomic Pharmaceuticals, Inc.
Phase 3
413
Elche, Madrid, Málaga
2018-07-17
Active, closed
PETHEMA Foundation
Phase 2
62
Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Murcia, Oviedo, Pamplona
2018-07-15
Active, closed
Myocardial FIbrosis in Repaired Tetralogy of FAllot- FIFA Study)
NCT04737135Congenital Heart Disease, Congenital Heart Defect, Fallot Tetralogy
Hospital Universitari Vall d'Hebron Research Institute
Observational
224
Madrid, Barcelona, Seville, Valencia
2018-07-09
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Pamplona, Badalona, Barcelona, Madrid
2018-06-26
Active, closed
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
NCT03485209Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer, Carcinoma, Squamous Cell of Head and Neck
DrugsTisotumab Vedotin·Tivdak·Keytruda·Cisplatin
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
350
Barcelona, Manresa, Madrid
2018-06-25
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Folinic acid·Fluorouracil·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
565
Badalona, Ávila, Alcorcón, Barcelona, Burgos, Madrid, Murcia, Seville
2018-06-21
Active, closed
Memorial Sloan Kettering Cancer Center
Phase 3
732
Oviedo, Madrid, Barcelona, Castellon, Seville, Valencia
2018-06-19
Active, closed
Exelixis
Phase 3
837
Santander, Majadahonda, Pamplona, Barcelona, Madrid, Valencia, Zaragoza
2018-06-10
Active, closed
Genentech, Inc.
Phase 1
123
Pozuelo de Alarcón, Barcelona, Madrid, Valencia
2018-06-06
Active, closed
Canadian Cancer Trials Group
Phase 2
129
Pamplona, Barcelona, Madrid, Valencia
2018-05-28
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
890
Pamplona, Badalona, Barcelona, Madrid, Santiago de Compostela
2018-05-21
Recruiting
BioInvent International AB
Phase 1/2
140
Badalona, Barcelona, Madrid, Murcia, Seville
2018-05-16
Active, closed
pharmaand GmbH
Phase 3
1,097
Barcelona, Bilbao, Castillón, El Palmar, Jerez de la Frontera, Madrid, Oviedo, Palma de Mallorca
2018-05-14
Active, closed
AstraZeneca
Phase 3
1,018
Badajoz, Barcelona, Elche(Alicante), Madrid, Málaga, Oviedo, Pamplona, Pozuelo de Alarcón
2018-05-14
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Alicante, Barcelona, Burgos, Donostia / San Sebastian, Madrid, Málaga, Valencia, Vigo
2018-05-14
Active, closed
Hoffmann-La Roche
Phase 1/2
211
Barcelona, Madrid, Málaga, Valencia
2018-05-08
Active, closed
Corcept Therapeutics
Phase 2
125
Alicante, Girona, Madrid, Málaga, Seville
2018-05-07
Active, closed
Centre Hospitalier Universitaire de Besancon
Not applicable
989
Barcelona, Castellon, Donostia / San Sebastian, Girona, Madrid, Vigo
2018-05-03
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
Barcelona, Madrid, Pamplona, Zaragoza
2018-05-03
Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
NCT03526835Advanced/Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
DrugPetosemtamab
Merus B.V.
Phase 1/2
560
Barcelona, Madrid, Pamplona, Valencia
2018-05-02
Active, closed
PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases
NCT03569241Prostate Cancer, Prostate Cancer Metastatic, Metastatic Cancer, Oligometastatic Cancer
University Hospital, Ghent
Phase 2
196
Barakaldo, Bilbao, Madrid, Navarro, Santiago, Valencia
2018-04-27
Active, closed
Rna Diagnostics Inc.
Not applicable
801
Madrid
2018-04-26
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Badalona, L'Hospitalet de Llobregat, Girona, Las Palmas de Gran Canaria, Barcelona, Madrid, Seville
2018-04-24
Active, closed
Pyruvate Kinase Deficiency Global Longitudinal Registry
NCT03481738Pyruvate Kinase Deficiency
Agios Pharmaceuticals, Inc.
Observational
500
Badalona, Esplugues de Llobregat, Barcelona, Madrid, Tortosa
2018-04-23
Active, closed
Bristol-Myers Squibb
Phase 3
545
Barcelona, Córdoba, Donostia / San Sebastian, Madrid, Pamplona, Sabadell (Barcelona), Seville, Valencia
2018-04-18
Active, closed
Janssen Research & Development, LLC
Phase 3
211
Barcelona, Madrid, Pamplona, Salamanca, Seville
2018-04-17
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
NCT03460977Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)
DrugsMevrometostat·Xtandi·Itraconazole·Enzalutamide
Pfizer
Phase 1
453
L'Hospitalet de Llobregat, Castellon, Pozuelo de Alarcón, Barcelona, Madrid, Málaga, Valencia
2018-04-17
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Córdoba, Ferrol, Girona, Huelva, Madrid, Oviedo, Pontevedra, Seville
2018-04-13
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
55
Barcelona, Madrid
2018-04-11
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
A Coruña, Barcelona, Madrid, San Sabastian Gipuzkoa, Seville
2018-04-11
Active, closed
Merck Sharp & Dohme LLC
Phase 2
340
Barcelona, Madrid
2018-04-09
Active, closed
AbbVie
Phase 3
1,336
Ferrol, L'Hospitalet de Llobregat, Sabadell, Majadahonda, Bilbao, Barcelona, Madrid, Salamanca
2018-04-09
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Barcelona, Madrid, Málaga, Ourense, Pontevedra, Pozuelo de Alarcón, Sabadell, Santander
2018-04-05
Active, closed
Y-mAbs Therapeutics
Phase 2
122
Barcelona, Madrid, Seville, Valencia
2018-04-03
Recruiting
Hoffmann-La Roche
Phase 1/2
1,132
Seville, Barcelona, Madrid
2018-03-30
Active, closed
BioLineRx, Ltd.
Phase 3
180
Barcelona, Madrid
2018-03-23
Active, closed
AstraZeneca
Phase 2
154
Barcelona, Madrid, Málaga, Santiago de Compostela
2018-03-16
Active, closed
AstraZeneca
Phase 2
273
Barcelona, Cáceres, Madrid, Palma de Mallorca, San Sebastián, Sant Cugat del Vallès, Seville, Valencia
2018-03-07
Active, closed
Janssen Research & Development, LLC
Phase 2
136
Barcelona, Madrid, Málaga
2018-03-02
Recruiting
Dabrafenib and/or Trametinib Rollover Study
NCT03340506Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers
DrugsDabrafenib·Trametinib
Novartis Pharmaceuticals
Phase 4
100
Barcelona, Madrid, Valencia
2018-01-26
Recruiting
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
NCT03142152Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases
Cardiac Dimensions, Inc.
Not applicable
300
Barcelona, Madrid, Valladolid
2018-01-01
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
NCT03394365Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant
DrugTabelecleucel
Pierre Fabre Medicament
Phase 3
115
Badalona, Barcelona, Santander, Madrid, Seville, Valencia
2017-12-29
Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
NCT03328078Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma, Refractory Primary Central Nervous System Lymphoma
DrugsEmavusertib·Ibrutinib
Curis, Inc.
Phase 1/2
152
Barcelona, Madrid, Seville
2017-12-28
Active, closed
Amgen
Phase 1
269
Barcelona, Madrid
2017-12-26
Active, closed
AstraZeneca
Phase 2
528
Barcelona, Madrid, Seville
2017-12-18
Active, closed
Pfizer
Phase 3
1,054
Santiago de Compostela, Elche, L'Hospitalet de Llobregat, Sabadell, El Palmar, Barcelona, Madrid
2017-12-18
Active, closed
Janssen Research & Development, LLC
Phase 1
279
Badalona, Madrid, Pamplona, Pozuelo de Alarcón, Salamanca
2017-12-16
Active, closed
Gilead Sciences
Phase 3
340
Badalona, Barcelona, Horcajo de la Sierra, Madrid, Málaga, Santander
2017-12-12
Active, closed
Sanofi
Phase 3
475
Barcelona, Madrid, Murcia
2017-12-07
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
61
Badalona, Madrid, Málaga, Salamanca, Valencia
2017-12-01
Active, closed
Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma
NCT02984410Oropharyngeal Cancer, Supraglottic Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
112
Barcelona, Madrid, Oviedo
2017-11-27
Active, closed
Genentech, Inc.
Phase 1
181
L'Hospitalet de Llobregat, Barcelona, Madrid, Valencia
2017-11-24
Active, closed
Registry of Secondary Revascularization
NCT03349385Coronary Artery Disease Progression, Coronary Artery Disease of Significant Bypass Graft, Stent Stenosis, Stent Restenosis
Hospital San Carlos, Madrid
Observational
869
Madrid
2017-11-22
Recruiting
Myocardial Ischemia Without Obstructive Coronary Stenoses
NCT04827498Myocardial Ischemia, Non-Obstructive Coronary Atherosclerosis, Microvascular Coronary Artery Disease, Vasospastic Angina
Hospital San Carlos, Madrid
Observational
600
Madrid
2017-11-08
Active, closed
BeiGene
Phase 3
590
Badalona, Barcelona, Madrid, Majadahonda, Pamplona, Valencia, Zaragoza
2017-10-31
Active, closed
Daiichi Sankyo
Phase 1
312
Barcelona, Madrid, Pamplona
2017-10-30
Active, closed
ViiV Healthcare
Phase 3
1,049
Badalona, Barcelona, Córdoba, Elche Alicante, Madrid, Málaga, Santiago de Compostela, Seville
2017-10-27
Active, closed
AstraZeneca
Phase 3
1,324
Barcelona, Madrid, Oviedo, Pamplona Madrid, Santander
2017-10-11
Recruiting
Immunoglobulin G4 and Immunoglobulin E Antibodies in a Population With Adverse Reactions to Foodstuffs-related Symptoms
NCT05681975Immunoglobulin E-Mediated Food Allergy, Immunoglobulin G4-Related Disease, Symptoms and Signs, Adverse Reaction to Food
Universidad Politecnica de Madrid
Observational
200
Madrid
2017-10-01
Recruiting
Apollomics Inc.
Phase 2
497
Badalona, Barcelona, Madrid, Valencia
2017-09-27
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
L'Hospitalet de Llobregat, Santiago de Compostela, Pamplona, Alicante, Barcelona, Madrid, Málaga, Seville
2017-09-22
Active, closed
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
NCT03212404Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell, Malignant Mesothelioma, Advanced
Checkpoint Therapeutics, Inc.
Phase 1
272
Barcelona, Madrid, Málaga, Pamplona, San Cristóbal de La Laguna, Seville, Valencia
2017-09-20
Active, closed
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
NCT03767348Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC), Cutaneous Melanoma
DrugsVusolimogene Oderparepvec·Opdivo·Nivolumab
Replimune, Inc.
Phase 2
340
Barcelona, Madrid, Murcia, Pamplona, Seville, Valencia
2017-09-20
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Barakaldo, Barcelona, Cartagena, El Palmar, Esplugues de Llobregat, Las Palmas de Gran Canaria, Madrid, Oviedo
2017-09-12
Active, closed
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
NCT03260023HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Anal Squamous Cell Carcinoma, HPV-Related Penile Squamous Cell Carcinoma
DrugAvelumab
Transgene
Phase 1/2
143
Badalona, Granada, Madrid, Málaga, Valencia
2017-09-01
Active, closed
Henares University Hospital
Observational
200
Arganda, Avilés, Oviedo, Talavera de la Reina, Madrid
2017-09-01
Active, closed
Novartis Pharmaceuticals
Phase 3
206
Donostia / San Sebastian, Barcelona, Madrid, Seville, Valencia
2017-08-23
Active, closed
Medtronic
Observational
1,092
A Coruña, Granada, Madrid, Salamanca, Santa Cruz de Tenerife, Santiago de Compostela, Valladolid
2017-08-21
Active, closed
Murdoch Childrens Research Institute
Phase 3
450
Madrid
2017-08-10
Active, closed
Asthma Research in Children and Adolescents
NCT04480242Persistent Asthma, Asthma in Children, Asthma Exacerbation
Parc de Salut Mar
Observational
525
Cadiz, Seville, Zaragoza, Alava, Torrelavega, Barcelona, Madrid, Valencia
2017-07-26
Active, closed
Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
NCT02952508Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
DrugCLR 131
Cellectar Biosciences, Inc.
Phase 2
120
Barcelona, Madrid, Salamanca, Zaragoza
2017-07-26
Recruiting
Prostate Cancer Clinical Trials Consortium
Observational
5,000
Barcelona, Málaga, Valencia, Badalona, Castellon, Madrid, Oviedo, Zaragoza
2017-07-21
Active, closed
Eli Lilly and Company
Phase 3
5,637
Córdoba, Barcelona, Santiago de Compostela, Lleida, Pozuelo de Alarcón, Alcorcón, Madrid, Málaga
2017-07-12
Active, closed
Novartis Pharmaceuticals
Phase 2
29
Madrid
2017-07-04
Active, closed
Hoffmann-La Roche
Phase 2
316
Sant Cugat del Vallès, Donostia / San Sebastian, Alcorcón, Pamplona/iruña, Barcelona, Madrid, Seville
2017-06-27
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
DrugsIvosidenib·Azacitidine
Institut de Recherches Internationales Servier
Phase 3
146
Santiago de Compostela, Palma de Mallorca, Badalona, Las Palmas de Gran Canaria, Barcelona, Madrid, Seville, Valencia
2017-06-26
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Barcelona, Madrid, Murcia, Salamanca, Seville, Valencia
2017-06-26
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
518
Barcelona, Madrid, Málaga, Murcia, Navarro, Salamanca, Santiago, Seville
2017-06-21
Active, closed
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
NCT03229200Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell, Graft Vs Host Disease
DrugIbrutinib
Pharmacyclics Switzerland GmbH
Phase 4
297
Badalona, Majadahonda, Barcelona, Madrid, Salamanca
2017-05-22
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
L'Hospitalet de Llobregat, Barcelona, Elche, Girona, Madrid, Málaga, Valencia, Valladolid
2017-05-03
Active, closed
Eli Lilly and Company
Phase 1/2
857
Barcelona, Madrid
2017-05-02
Active, closed
Pfizer
Phase 3
296
L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Majadahonda, Pamplona, A Coruña, Barcelona, Girona, Madrid
2017-04-27
Active, closed
Acerta Pharma BV
Phase 3
635
Badalona, Barcelona, Madrid, Majadahonda, Pamplona, Seville, Valencia
2017-04-05
Active, closed
AstraZeneca
Phase 3
987
A Coruña, Badajoz, Badalona, Barcelona, Madrid, Santander, Valencia, Zaragoza
2017-03-27
Active, closed
Bristol-Myers Squibb
Phase 3
1,314
A Coruña, Barcelona, Madrid, Santander, Seville, Valencia
2017-03-24
Recruiting
Italian Sarcoma Group
Not applicable
100
Barcelona, Madrid, Seville, Valencia
2017-03-16
Recruiting
Turning Point Therapeutics, Inc.
Phase 1/2
500
Barcelona, Madrid, Pamplona, Valencia
2017-03-07
Active, closed
European Association of Urology Research Foundation
Observational
1,054
Barcelona, Granada, Madrid, Murcia, San Cristóbal de La Laguna, Valencia
2017-02-22
Active, closed
AbbVie
Phase 1
163
Majadahonda, Madrid, Valencia
2017-02-22
Active, closed
Hoffmann-La Roche
Phase 1/2
940
Badalona, L'Hospitalet de Llobregat, Santander, Barcelona, Madrid
2017-02-21
Active, closed
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
NCT03069469Advanced Malignant Neoplasm, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor
DrugVimseltinib
Deciphera Pharmaceuticals, LLC
Phase 1/2
120
Barcelona, Madrid, Seville
2017-02-16
Active, closed
Persona Partial Knee Clinical Outcomes Study
NCT03034811Osteoarthritis, Avascular Necrosis, Traumatic Arthritis, Conditional Tibial Condyle or Plateau Fractures
Zimmer Biomet
Not applicable
757
Madrid
2017-02-08
Active, closed
Acerta Pharma BV
Phase 3
310
Badalona, Madrid, Majadahonda, Salamanca, Santander, Valencia
2017-02-02
Active, closed
AbbVie
Phase 3
443
Pamplona, Barcelona, Madrid, Málaga, Valencia
2017-02-02
Active, closed
ITM Solucin GmbH
Phase 3
324
Barcelona, Madrid, Oviedo, Valencia
2017-02-02
Active, closed
AbbVie
Phase 3
950
A Coruña, Santiago de Compostela, Santander, Las Palmas de Gran Canaria, Barcelona, Córdoba, Madrid, Salamanca
2017-01-31
Active, closed
AbbVie
Phase 2
120
Badalona, Barcelona, Madrid
2017-01-19
Recruiting
University College, London
Observational
2,500
Bilbao, Barcelona, Madrid
2017-01-01
Active, closed
AstraZeneca
Phase 1
117
Badalona, Barcelona, Madrid
2016-12-28
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Barcelona, Girona, Madrid, Pamplona, Salamanca, Santiago de Compostela
2016-12-22
Active, closed
Janssen Biotech, Inc.
Observational
535
A Coruña, Barcelona, Córdoba, Fuenlabrada, Huelva, Madrid, Majadahonda, San Sebastián de los Reyes
2016-12-16
Active, closed
Ribociclib (LEE011) Rollover Study for Continued Access
NCT02934568Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies
DrugRibociclib
Novartis Pharmaceuticals
Phase 2
22
Madrid
2016-12-15
Active, closed
Target PharmaSolutions, Inc.
Observational
10,000
Madrid, Pamplona, Santander, Seville, Valencia
2016-12
Recruiting
Neurovascular Product Surveillance Registry
NCT02988128Intracranial Aneurysm, Stroke, Ischemic
Medtronic Neurovascular Clinical Affairs
Observational
4,000
Barakaldo, Barcelona, Madrid, Oviedo, San Sebastián, Seville, Valladolid, Vigo
2016-12
Active, closed
Janssen Research & Development, LLC
Phase 1/2
234
Badalona, Barcelona, Madrid, Málaga, Pamplona, Seville, Valencia
2016-11-21
Active, closed
Eli Lilly and Company
Phase 1
223
Barcelona, Madrid, Valencia
2016-11-21
Active, closed
Eli Lilly and Company
Phase 1
100
Ávila, Cáceres, Madrid
2016-11-14
Active, closed
ViiV Healthcare
Phase 3
618
Badalona, Barcelona, Córdoba, Elche Alicante, Madrid, Málaga, Santiago de Compostela, Seville
2016-10-28
Active, closed
ViiV Healthcare
Phase 3
631
A Coruña, Barcelona, Bilbao, Elche Alicante, Ferrol, Granada, La Laguna Santa Cruz, Madrid
2016-10-27
Active, closed
Celgene
Phase 1/2
466
Badalona (Barcelona), Barcelona, Madrid, Pamplona, Valencia
2016-10-14
Active, closed
Eisai Inc.
Phase 3
1,069
Santander, Barcelona, Cáceres, Córdoba, Madrid, Oviedo, Seville, Valencia
2016-10-13
Active, closed
Eli Lilly and Company
Phase 2
234
Barcelona, Madrid, Valencia
2016-09-14
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Barcelona, Cartagena, Jerez de la Frontera, Madrid, Málaga, San Sebastián de los Reyes, Sant Cugat del Vallès, Seville
2016-09-13
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2
472
Barcelona, Madrid, Valencia
2016-08-03
Active, closed
Tesaro, Inc.
Phase 3
733
Badalona, Barcelona, Córdoba, Donostia / San Sebastian, Elche Alicante, Girona, Madrid, Seville
2016-07-11
Active, closed
Tesaro, Inc.
Phase 1
463
Barcelona, Girona, Jerez de la Frontera, L'Hospitalet de Llobrega, Las Palmas de Gran Canar, Madrid, Málaga, Palma de Mallorca
2016-07-08
Active, closed
iSTAR Medical
Observational
70
Madrid
2016-07
Active, closed
Celgene
Phase 1/2
130
Barcelona, Cáceres, Madrid, Málaga, Valencia
2016-06-03
Active, closed
Janssen Research & Development, LLC
Phase 1
751
A Coruña, Barcelona, Madrid, Málaga, Santander, Seville
2016-05-24
Active, closed
Eli Lilly and Company
Phase 2
309
L'Hospitalet de Llobregat, Barcelona, Madrid
2016-05-19
Active, closed
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2
50
Barcelona, Terrassa, Burgos, Alcorcón, Madrid, Cartagena, Marbella, Seville
2016-05-18
Active, closed
NeuroDerm Ltd.
Phase 2
214
Barcelona, Madrid
2016-05-04
Active, closed
Hoffmann-La Roche
Phase 1/2
69
Madrid
2016-05-03
Recruiting
Quality of Pediatric Resuscitation in a Multicenter Collaborative
NCT02708134Cardiac Arrest, Cardiopulmonary Arrest
Children's Hospital of Philadelphia
Observational
7,000
Madrid
2016-05-02
Recruiting
UMC Utrecht
Phase 3
20,000
Barcelona, Cadiz, Córdoba, Madrid, Málaga, Ourense, Santander, Tortosa
2016-04-11
Active, closed
Acerta Pharma BV
Phase 2
60
Madrid
2016-03-08
Active, closed
Tesaro, Inc.
Phase 1
729
Santiago de Compostela, Barcelona, Girona, Madrid, Málaga, Murcia, Pamplona, Santander
2016-03-07
Recruiting
Boston Scientific Corporation
Observational
300
Barcelona, El Palmar, Madrid, Oviedo
2016-03-07
Active, closed
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
NCT02710435Angina Pectoris, Angina Pectoris, Stable, Chronic Stable Angina
Shockwave Medical, Inc.
Observational
400
Madrid
2016-03
Active, closed
MedImmune LLC
Phase 1/2
383
Barcelona, Madrid, Málaga, Pamplona, Seville
2016-02-22
Active, closed
Geron Corporation
Phase 2/3
289
Cadiz, Majadahonda, Seville, Valencia, Barakaldo, Badalona, Barcelona, Madrid
2016-01-12
By invitation
Universidad Autonoma de Madrid
Observational
4,000
Madrid
2016-01
Active, closed
Novartis Pharmaceuticals
Phase 4
233
A Coruña, Barcelona, Madrid, Málaga
2015-12-11
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Barcelona, Córdoba, Jerez de la Frontera, Madrid, Pamplona
2015-11-27
Active, closed
Hoffmann-La Roche
Phase 2
534
Fuenlabrada, Barcelona, Madrid, Málaga, Seville
2015-11-19
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Barakaldo, Barcelona, Castellon, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Málaga, Reus
2015-11-19
Active, closed
AstraZeneca
Phase 3
1,126
Badajoz, Badalona, Barcelona, Elche(Alicante), Madrid, Pozuelo de Alarcón, Santiago de Compostela, Seville
2015-11-02
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,105
Esplugues, L'Hospitalet de Llobregat, Pamplona, Barcelona, Madrid, Salamanca, Seville, Valencia
2015-11-02
Active, closed
AstraZeneca
Phase 3
682
A Coruña, Barcelona, Donostia / San Sebastian, Elche, Las Palmas de Gran Canaria, Madrid, Majadahonda, Málaga
2015-10-21
Active, closed
Phase III Radium 223 mCRPC-PEACE III
NCT02194842Prostate Cancer
DrugsRa223·Enzalutamide
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
446
Barcelona, Madrid, Pamplona, Sabadell, Salamanca
2015-10
Active, closed
Alliance for Clinical Trials in Oncology
Phase 3
420
Barcelona, Madrid, Murcia
2015-08-06
Active, closed
Acerta Pharma BV
Phase 3
533
Barcelona, Madrid, Majadahonda, Murcia, Santander
2015-07-28
Active, closed
AstraZeneca
Phase 3
1,118
A Coruña, Alicante, Barcelona, Girona, Jaén, León, Madrid, Majadahonda
2015-07-21
Active, closed
Taiho Oncology, Inc.
Phase 1/2
253
Girona, Pamplona, Madrid
2015-07-14
Active, closed
Acerta Pharma BV
Phase 3
535
Barcelona, Madrid, Majadahonda, Santander
2015-06-26
Active, closed
Eli Lilly and Company
Phase 3
545
Barcelona, Hospitalet, Palma, Pozuelo de Alarcón, Madrid, Pamplona, Seville, Valencia
2015-05-06
Active, closed
PETHEMA Foundation
Phase 2
90
Barcelona, Madrid, Murcia, Oviedo, Pamplona, Plama de Mallorca, Salamanca, Santa Cruz de Tenerife
2015-05
Active, closed
Janssen Research & Development, LLC
Phase 2
239
Badalona, Barcelona, Madrid, Málaga, Pamplona, Sabadell, Santander, Santiago de Compostela
2015-04-22
Active, closed
Exelixis
Phase 4
247
Barcelona, Madrid
2015-02-25
Active, closed
ViiV Healthcare
Phase 3
371
Badalona, Barcelona, Madrid, Seville
2015-02-23
By invitation
Registry of Patients With Hypophosphatasia
NCT02306720Hypophosphatasia (HPP)
Alexion Pharmaceuticals, Inc.
Observational
1,571
Madrid
2015-01-20
Active, closed
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
NCT02912949Solid Tumours Harboring NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, NRG1 Fusion
DrugBispecific
Partner Therapeutics, Inc.
Phase 2
250
Barcelona, Madrid, Pamplona, Valencia
2015-01
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsLupron·Eligard·Leuprorelin·Xtandi
Pfizer
Phase 3
1,068
Palma de Mallorca, Manresa, Santiago de Compostela, Barcelona, Cadiz, Girona, Madrid, Ourense
2014-12-17
Rows per page Showing 2501–3000 of 3046
Previous 4 5 6 7 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-spain/city/madrid?page=6

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,046 of those studies with a site in Madrid.

How many clinical trials are recruiting in Madrid?

1,554 of the 3,046 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 117 have not yet opened recruitment, 1,309 are active but closed to new participants, and 66 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.